Association of G12D mutation in the KRAS gene with HPV and EBV in gastrointestinal cancer tissues

Objective This study aimed to explore the potential relationship between viral infections and gastrointestinal (GI) malignancies, focusing on the presence of KRAS G12D mutations. Specifically, we investigated the association of viral agents, including human papillomavirus (HPV) and Epstein–Barr viru...

Full description

Saved in:
Bibliographic Details
Main Authors: Vahideh Hamidi Sofiani, Arefeh Ebrahimian Shiadeh, Alijan Tabarraei, Hadi Razavi Nikoo, Farzin Sadeghi, Ghodsieh Kamrani, Yousef Yahyapour, Abdolvahab Moradi
Format: Article
Language:English
Published: SAGE Publishing 2024-12-01
Series:Journal of International Medical Research
Online Access:https://doi.org/10.1177/03000605241302302
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850104300661899264
author Vahideh Hamidi Sofiani
Arefeh Ebrahimian Shiadeh
Alijan Tabarraei
Hadi Razavi Nikoo
Farzin Sadeghi
Ghodsieh Kamrani
Yousef Yahyapour
Abdolvahab Moradi
author_facet Vahideh Hamidi Sofiani
Arefeh Ebrahimian Shiadeh
Alijan Tabarraei
Hadi Razavi Nikoo
Farzin Sadeghi
Ghodsieh Kamrani
Yousef Yahyapour
Abdolvahab Moradi
author_sort Vahideh Hamidi Sofiani
collection DOAJ
description Objective This study aimed to explore the potential relationship between viral infections and gastrointestinal (GI) malignancies, focusing on the presence of KRAS G12D mutations. Specifically, we investigated the association of viral agents, including human papillomavirus (HPV) and Epstein–Barr virus (EBV), with KRAS G12D mutations in GI cancers to better understand their combined role in cancer development. Methods This cross-sectional study comprised 92 patients diagnosed with GI cancer and 100 healthy individuals in the control group. All samples were examined to detect the KRAS G12D gene mutation and the existence of HPV and EBV using real-time polymerase chain reaction assays. Results HPV and EBV DNA were detected in 5.4% and 51.4% of gastric cancer samples and in 7.3% and 49.1% of colorectal cancer samples, respectively. Analysis of KRAS G12D in plasma samples revealed heterozygous mutations in 54% of patients with gastric cancer and 35% of patients with colorectal tumors. Among EBV-positive colorectal cancer samples, 1.8% were wild-type, while 47.2% exhibited heterozygous mutations. Among HPV-positive colorectal cancer patients, 1.8% exhibited wild-type KRAS, 5.4% had heterozygous mutations, and 3.2% had homozygous mutations. Conclusion This study detected a significant correlation between the presence of viral agents and KRAS G12D mutations.
format Article
id doaj-art-59be707ce62d4c8b93c0f9a380e5304e
institution DOAJ
issn 1473-2300
language English
publishDate 2024-12-01
publisher SAGE Publishing
record_format Article
series Journal of International Medical Research
spelling doaj-art-59be707ce62d4c8b93c0f9a380e5304e2025-08-20T02:39:21ZengSAGE PublishingJournal of International Medical Research1473-23002024-12-015210.1177/03000605241302302Association of G12D mutation in the KRAS gene with HPV and EBV in gastrointestinal cancer tissuesVahideh Hamidi SofianiArefeh Ebrahimian ShiadehAlijan TabarraeiHadi Razavi NikooFarzin SadeghiGhodsieh KamraniYousef YahyapourAbdolvahab MoradiObjective This study aimed to explore the potential relationship between viral infections and gastrointestinal (GI) malignancies, focusing on the presence of KRAS G12D mutations. Specifically, we investigated the association of viral agents, including human papillomavirus (HPV) and Epstein–Barr virus (EBV), with KRAS G12D mutations in GI cancers to better understand their combined role in cancer development. Methods This cross-sectional study comprised 92 patients diagnosed with GI cancer and 100 healthy individuals in the control group. All samples were examined to detect the KRAS G12D gene mutation and the existence of HPV and EBV using real-time polymerase chain reaction assays. Results HPV and EBV DNA were detected in 5.4% and 51.4% of gastric cancer samples and in 7.3% and 49.1% of colorectal cancer samples, respectively. Analysis of KRAS G12D in plasma samples revealed heterozygous mutations in 54% of patients with gastric cancer and 35% of patients with colorectal tumors. Among EBV-positive colorectal cancer samples, 1.8% were wild-type, while 47.2% exhibited heterozygous mutations. Among HPV-positive colorectal cancer patients, 1.8% exhibited wild-type KRAS, 5.4% had heterozygous mutations, and 3.2% had homozygous mutations. Conclusion This study detected a significant correlation between the presence of viral agents and KRAS G12D mutations.https://doi.org/10.1177/03000605241302302
spellingShingle Vahideh Hamidi Sofiani
Arefeh Ebrahimian Shiadeh
Alijan Tabarraei
Hadi Razavi Nikoo
Farzin Sadeghi
Ghodsieh Kamrani
Yousef Yahyapour
Abdolvahab Moradi
Association of G12D mutation in the KRAS gene with HPV and EBV in gastrointestinal cancer tissues
Journal of International Medical Research
title Association of G12D mutation in the KRAS gene with HPV and EBV in gastrointestinal cancer tissues
title_full Association of G12D mutation in the KRAS gene with HPV and EBV in gastrointestinal cancer tissues
title_fullStr Association of G12D mutation in the KRAS gene with HPV and EBV in gastrointestinal cancer tissues
title_full_unstemmed Association of G12D mutation in the KRAS gene with HPV and EBV in gastrointestinal cancer tissues
title_short Association of G12D mutation in the KRAS gene with HPV and EBV in gastrointestinal cancer tissues
title_sort association of g12d mutation in the kras gene with hpv and ebv in gastrointestinal cancer tissues
url https://doi.org/10.1177/03000605241302302
work_keys_str_mv AT vahidehhamidisofiani associationofg12dmutationinthekrasgenewithhpvandebvingastrointestinalcancertissues
AT arefehebrahimianshiadeh associationofg12dmutationinthekrasgenewithhpvandebvingastrointestinalcancertissues
AT alijantabarraei associationofg12dmutationinthekrasgenewithhpvandebvingastrointestinalcancertissues
AT hadirazavinikoo associationofg12dmutationinthekrasgenewithhpvandebvingastrointestinalcancertissues
AT farzinsadeghi associationofg12dmutationinthekrasgenewithhpvandebvingastrointestinalcancertissues
AT ghodsiehkamrani associationofg12dmutationinthekrasgenewithhpvandebvingastrointestinalcancertissues
AT yousefyahyapour associationofg12dmutationinthekrasgenewithhpvandebvingastrointestinalcancertissues
AT abdolvahabmoradi associationofg12dmutationinthekrasgenewithhpvandebvingastrointestinalcancertissues